179 related articles for article (PubMed ID: 8637244)
1. Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
O'Brien S; Jeha S; Kantarjian H; Pisa P; Jin G; Keating M; Beran M
Leukemia; 1996 Feb; 10(2):338-44. PubMed ID: 8637244
[TBL] [Abstract][Full Text] [Related]
2. Engraftment of human chronic lymphocytic leukemia cells in SCID mice: in vivo and in vitro studies.
Hummel JL; Lichty BD; Reis M; Dubé I; Kamel-Reid S
Leukemia; 1996 Aug; 10(8):1370-6. PubMed ID: 8709647
[TBL] [Abstract][Full Text] [Related]
3. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
4. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
[TBL] [Abstract][Full Text] [Related]
5. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M
Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433
[TBL] [Abstract][Full Text] [Related]
6. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
[TBL] [Abstract][Full Text] [Related]
7. T gamma lymphocytosis and T cell chronic leukemias.
Berliner N
Hematol Oncol Clin North Am; 1990 Apr; 4(2):473-87. PubMed ID: 2182603
[TBL] [Abstract][Full Text] [Related]
8. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
9. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
10. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
12. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
13. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
14. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma.
Hermouet S; Sutton CA; Rose TM; Greenblatt RJ; Corre I; Garand R; Neves AM; Bataille R; Casey JW
Leukemia; 2003 Jan; 17(1):185-95. PubMed ID: 12529677
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotype of chronic lymphocytic leukemia and prolymphocytic leukemia].
Maruyama S
Nihon Rinsho; 1992 Jun; 50(6):1236-40. PubMed ID: 1518139
[TBL] [Abstract][Full Text] [Related]
17. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
18. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice.
Wong KK; Brenneman F; Chesney A; Spaner DE; Gorczynski RM
Cancer Res; 2012 Oct; 72(19):4931-43. PubMed ID: 22875025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]